Quadrant Capital Group’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $409K | Buy |
21,272
+785
| +4% | +$15.5K | 0.01% | 1000 |
|
|
2025
Q4 | $388K | Buy |
20,487
+3,277
| +19% | +$60.7K | 0.01% | 1048 |
|
|
2025
Q3 | $321K | Buy |
17,210
+34
| +0.2% | +$635 | 0.01% | 1098 |
|
|
2025
Q2 | $317K | Sell |
17,176
-563
| -3% | -$9.99K | 0.01% | 1109 |
|
|
2025
Q1 | $310K | Buy |
17,739
+14,559
| +458% | +$245K | 0.01% | 1073 |
|
|
2024
Q4 | $55.1K | Buy |
3,180
+38
| +1% | +$694 | ﹤0.01% | 1361 |
|
|
2024
Q3 | $58.5K | Hold |
3,142
| – | – | ﹤0.01% | 1369 |
|
|
2024
Q2 | $48.4K | Buy |
3,142
+805
| +34% | +$11.5K | ﹤0.01% | 1420 |
|
|
2024
Q1 | $34.5K | Buy |
2,337
+504
| +27% | +$6.98K | ﹤0.01% | 1591 |
|
|
2023
Q4 | $26.2K | Buy |
1,833
+38
| +2% | +$540 | ﹤0.01% | 1693 |
|
|
2023
Q3 | $25K | Hold |
1,795
| – | – | ﹤0.01% | 1595 |
|
|
2023
Q2 | $21.1K | Buy |
1,795
+1,158
| +182% | +$13.2K | ﹤0.01% | 1695 |
|
|
2023
Q1 | $7.33K | Buy |
637
+422
| +196% | +$5.22K | ﹤0.01% | 2144 |
|
|
2022
Q4 | $2.67K | Sell |
215
-235
| -52% | -$3K | ﹤0.01% | 2339 |
|
|
2022
Q3 | $6K | Sell |
450
-302
| -40% | -$4.46K | ﹤0.01% | 2092 |
|
|
2022
Q2 | $11K | Sell |
752
-717
| -49% | -$9.59K | ﹤0.01% | 1621 |
|
|
2022
Q1 | $22K | Buy |
1,469
+96
| +7% | +$1.31K | ﹤0.01% | 1291 |
|
|
2021
Q4 | $19K | Buy |
1,373
+97
| +8% | +$1.37K | ﹤0.01% | 1339 |
|
|
2021
Q3 | $19K | Sell |
1,276
-23
| -2% | -$389 | ﹤0.01% | 1268 |
|
|
2021
Q2 | $24K | Sell |
1,299
-281
| -18% | -$5K | ﹤0.01% | 1127 |
|
|
2021
Q1 | $27K | Hold |
1,580
| – | – | ﹤0.01% | 1061 |
|
|
2020
Q4 | $27K | Buy |
1,580
+349
| +28% | +$5.57K | 0.01% | 981 |
|
|
2020
Q3 | $17K | Hold |
1,231
| – | – | ﹤0.01% | 1032 |
|
|
2020
Q2 | $18K | Buy |
1,231
+96
| +8% | +$1.26K | ﹤0.01% | 1103 |
|
|
2020
Q1 | $12K | Sell |
1,135
-2,670
| -70% | -$49.2K | ﹤0.01% | 1405 |
|
|
2019
Q4 | $79K | Buy |
3,805
+501
| +15% | +$11.2K | 0.01% | 1104 |
|
|
2019
Q3 | $75K | Hold |
3,304
| – | – | 0.01% | 1047 |
|
|
2019
Q2 | $64K | Buy |
3,304
+3,198
| +3,017% | +$62.3K | 0.01% | 1100 |
|
|
2019
Q1 | $2K | Sell |
106
-699
| -87% | -$13.2K | ﹤0.01% | 2087 |
|
|
2018
Q4 | $12K | Buy |
805
+394
| +96% | +$7.93K | ﹤0.01% | 1343 |
|
|
2018
Q3 | $9K | Hold |
411
| – | – | ﹤0.01% | 1346 |
|
|
2018
Q2 | $8K | Buy |
411
+268
| +187% | +$5.23K | ﹤0.01% | 1385 |
|
|
2018
Q1 | $2K | Sell |
143
-319
| -69% | -$5.62K | ﹤0.01% | 1881 |
|
|
2017
Q4 | $7K | Sell |
462
-155
| -25% | -$3.08K | ﹤0.01% | 1355 |
|
|
2017
Q3 | $11K | Buy |
+617
| New | +$13.9K | ﹤0.01% | 1145 |
|
|
2016
Q1 | – | Sell |
-293
| Closed | -$5K | – | 1955 |
|
|
2015
Q4 | $5K | Buy |
+293
| New | +$6.17K | ﹤0.01% | 1119 |
|
Other funds holding SBRA
VPM
VCM
N
Quadrant Capital Group's SBRA Position: Q1 2026 in Review
Quadrant Capital Group increased its Sabra Healthcare REIT (SBRA) stake by 3.8% in Q1 2026, buying an estimated $15.5K and bringing the position to 21,272 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #1000.
Quadrant Capital Group first reported a position in SBRA in Q4 2015 and has held it in 36 quarters since. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Quadrant Capital Group held 21,272 shares of Sabra Healthcare REIT worth $409K as of Q1 2026.
- Quadrant Capital Group bought 785 Sabra Healthcare REIT shares in Q1 2026, an estimated $15.5K.
- Sabra Healthcare REIT made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1000 holding.
- Quadrant Capital Group first reported a position in Sabra Healthcare REIT in Q4 2015 and has held it in 36 quarters since.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.